<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34694037</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of paediatrics and child health</Title><ISOAbbreviation>J Paediatr Child Health</ISOAbbreviation></Journal><ArticleTitle>COVID-19 in children. II: Pathogenesis, disease spectrum and management.</ArticleTitle><Pagination><StartPage>46</StartPage><EndPage>53</EndPage><MedlinePgn>46-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jpc.15811</ELocationID><Abstract><AbstractText>The global disruption of the COVID-19 pandemic has impacted the life of every child either directly or indirectly. This review explores the pathophysiology, immune response, clinical presentation and treatment of COVID-19 in children, summarising the most up-to-date data including recent developments regarding variants of concern. The acute infection with SARS-CoV-2 is generally mild in children, whilst the post-infectious manifestations, including paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) and 'long COVID' in children, are more complex. Given that most research on COVID-19 has focused on adult cohorts and that clinical manifestations, treatment availability and impacts differ markedly in children, research that specifically examines COVID-19 in children needs to be prioritised.</AbstractText><CopyrightInformation>&#xa9; 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Howard-Jones</LastName><ForeName>Annaleise R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-9756-2813</Identifier><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NSW Health Pathology-Nepean, Nepean Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgner</LastName><ForeName>David P</ForeName><Initials>DP</Initials><Identifier Source="ORCID">0000-0002-8304-4302</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawford</LastName><ForeName>Nigel W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goeman</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuek</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Sleep Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMullan</LastName><ForeName>Brendan J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0001-5144-3416</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosif</LastName><ForeName>Shidan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0022-1009</Identifier><AffiliationInfo><Affiliation>Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wurzel</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory and Sleep Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Asha C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danchin</LastName><ForeName>Margie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7624-5691</Identifier><AffiliationInfo><Affiliation>Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koirala</LastName><ForeName>Archana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2567-8825</Identifier><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Immunisation Research and Surveillance, The&#x2009;Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Nepean Hospital, Penrith, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ketaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Immunisation Research and Surveillance, The&#x2009;Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeoh</LastName><ForeName>Daniel K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0002-6284-612X</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britton</LastName><ForeName>Philip N</ForeName><Initials>PN</Initials><Identifier Source="ORCID">0000-0002-2993-6000</Identifier><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Paediatr Child Health</MedlineTA><NlmUniqueID>9005421</NlmUniqueID><ISSNLinking>1034-4810</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PIMS-TS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">management</Keyword><Keyword MajorTopicYN="N">virology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>25</Day><Hour>8</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34694037</ArticleId><ArticleId IdType="pmc">PMC8662268</ArticleId><ArticleId IdType="doi">10.1111/jpc.15811</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Weekly Epidemiological Update on COVID&#x2010;19: Edition 50. Geneva: WHO; 2021.</Citation></Reference><Reference><Citation>Wu F, Zhao S, Yu B et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579: 265&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K, Koirala A, Nicolopoulos K, Chiu C, Wood N, Britton PN. Vaccines for COVID&#x2010;19: Where do we stand in 2021? Paediatr. Respir. Rev. 2021; 39: 22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274273</ArticleId><ArticleId IdType="pubmed">34362666</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HL, Lan PD, Thai NQ, Nissley DA, O'Brien EP, Li MS. Does SARS&#x2010;CoV&#x2010;2 bind to human ACE2 more strongly than does SARS&#x2010;CoV? J. Phys. Chem. B 2020; 124: 7336&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7433338</ArticleId><ArticleId IdType="pubmed">32790406</ArticleId></ArticleIdList></Reference><Reference><Citation>Khateeb J, Li Y, Zhang H. Emerging SARS&#x2010;CoV&#x2010;2 variants of concern and potential intervention approaches. Critical Care (London, England) 2021; 25: 244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274962</ArticleId><ArticleId IdType="pubmed">34253247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin&#x2010;converting enzyme 2 in children and adults. JAMA 2020; 323: 2427&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240631</ArticleId><ArticleId IdType="pubmed">32432657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID&#x2010;19? J Microbiol Immunol Infect 2020; 53: 371&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102573</ArticleId><ArticleId IdType="pubmed">32147409</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosif S, Neeland MR, Sutton P et al. Immune responses to SARS&#x2010;CoV&#x2010;2 in three children of parents with symptomatic COVID&#x2010;19. Nat. Commun. 2020; 11: 5703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658256</ArticleId><ArticleId IdType="pubmed">33177504</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske J, R&#xf6;hmel J, Lukassen S et al. Pre&#x2010;activated antiviral innate immunity in the upper airways controls early SARS&#x2010;CoV&#x2010;2 infection in children. Nat. Biotechnol. 2021. 10.1038/s41587-021-01037-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01037-9</ArticleId><ArticleId IdType="pubmed">34408314</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeland MR, Bannister S, Clifford V et al. Innate cell profiles during the acute and convalescent phase of SARS&#x2010;CoV&#x2010;2 infection in children. Nat. Commun. 2021; 12: 1084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889848</ArticleId><ArticleId IdType="pubmed">33597531</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg SP, Connors TJ, Zhu Y et al. Distinct antibody responses to SARS&#x2010;CoV&#x2010;2 in children and adults across the COVID&#x2010;19 clinical spectrum. Nat. Immunol. 2021; 22: 25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136619</ArticleId><ArticleId IdType="pubmed">33154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Selva KJ, van de Sandt CE, Lemke MM et al. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat. Commun. 2021; 12: 2037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016934</ArticleId><ArticleId IdType="pubmed">33795692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacher P, Rosati E, Esser D et al. Low&#x2010;avidity CD4(+) T cell responses to SARS&#x2010;CoV&#x2010;2 in unexposed individuals and humans with severe COVID&#x2010;19. Immunity 2020; 53: 1258&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689350</ArticleId><ArticleId IdType="pubmed">33296686</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer DB. The effect of age on thymic function. Front. Immunol. 2013; 4: 316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791471</ArticleId><ArticleId IdType="pubmed">24109481</ArticleId></ArticleIdList></Reference><Reference><Citation>Korakas E, Ikonomidis I, Kousathana F et al. Obesity and COVID&#x2010;19: Immune and metabolic derangement as a possible link to adverse clinical outcomes. Am. J. Physiol. Endocrinol. Metab. 2020; 319: E105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322508</ArticleId><ArticleId IdType="pubmed">32459524</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N. Association between HLA genotypes and COVID&#x2010;19 susceptibility, severity and progression: A comprehensive review of the literature. Eur. J. Med. Res. 2021; 26: 84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329616</ArticleId><ArticleId IdType="pubmed">34344463</ArticleId></ArticleIdList></Reference><Reference><Citation>Langton DJ, Bourke SC, Lie BA et al. The influence of HLA genotype on the severity of COVID&#x2010;19 infection. HLA 2021; 98: 14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251294</ArticleId><ArticleId IdType="pubmed">33896121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurzel D et al. COVID&#x2010;19 and its multi&#x2010;system inflammatory complications in children &#x2010; a multi&#x2010;centre nationwide Australian study. BMJ Open. 2021; in press</Citation></Reference><Reference><Citation>Liguoro I, Pilotto C, Bonanni M et al. SARS&#x2010;COV&#x2010;2 infection in children and newborns: A systematic review. Eur. J. Pediatr. 2020; 179: 1029&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234446</ArticleId><ArticleId IdType="pubmed">32424745</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020; 383: 334&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS&#x2010;CoV&#x2010;2. JAMA 2020; 324: 259&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner RM, Ward JL, Hudson LD et al. Systematic review of reviews of symptoms and signs of COVID&#x2010;19 in children and adolescents. Arch. Dis. Child. 2020; 106: 802&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID&#x2010;19: A systematic review and meta&#x2010;analysis. Arch. Dis. Child. 2021; 106: 440&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8070630</ArticleId><ArticleId IdType="pubmed">33593743</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS et al. Illness duration and symptom profile in symptomatic UKschool&#x2010;aged children tested for SARS&#x2010;CoV&#x2010;2. Lancet Child Adolesc Health 2021; 5: 708&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzinger F, Santiago&#x2010;Garc&#xed;a B, Noguera&#x2010;Juli&#xe1;n A et al. COVID&#x2010;19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child Adolesc Health 2020; 4: 653&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316447</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId></ArticleIdList></Reference><Reference><Citation>Parcha V, Booker KS, Kalra R et al. A retrospective cohort study of 12,306 pediatric COVID&#x2010;19 patients in the United States. Sci. Rep. 2021; 11: 10231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119690</ArticleId><ArticleId IdType="pubmed">33986390</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale C, Quigley MA, Placzek A et al. Characteristics and outcomes of neonatal SARS&#x2010;CoV&#x2010;2 infection in the UK: A prospective national cohort study using active surveillance. Lancet Child Adolesc Health 2021; 5: 113&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818530</ArticleId><ArticleId IdType="pubmed">33181124</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Zhao Z, Zhang T et al. A systematic review and meta&#x2010;analysis of children with coronavirus disease 2019 (COVID&#x2010;19). J. Med. Virol. 2021; 93: 1057&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436402</ArticleId><ArticleId IdType="pubmed">32761898</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisca G, Mallamaci M, Tardini G et al. SARS&#x2010;CoV&#x2010;2 infection may present as acute hepatitis in children. Pediatr. Infect. Dis. J. 2021; 40: e214&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33591076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray STJ, Abdel&#x2010;Mannan O, Sa M et al. Neurological manifestations of SARS&#x2010;CoV&#x2010;2 infection in hospitalised children and adolescents in the UK: A prospective national cohort study. Lancet Child Adolesc Health 2021; 5: 631&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279959</ArticleId><ArticleId IdType="pubmed">34273304</ArticleId></ArticleIdList></Reference><Reference><Citation>Abi Nassif T, Fakhri G, Younis NK et al. Cardiac manifestations in COVID&#x2010;19 patients: A focus on the pediatric population. Can. J. Infect. Dis. Med. Microbiol. 2021; 2021: 5518979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287458</ArticleId><ArticleId IdType="pubmed">34326911</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana J, Poirault C, Corsia A et al. Kawasaki&#x2010;like multisystem inflammatory syndrome in children during the covid&#x2010;19 pandemic in Paris, France: Prospective observational study. BMJ (Clin Res ed) 2020; 369: m2094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500538</ArticleId><ArticleId IdType="pubmed">32493739</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams PCM, Howard&#x2010;Jones AR, Hsu P et al. SARS&#x2010;CoV&#x2010;2 in children: Spectrum of disease, transmission and immunopathological underpinnings. Pathology 2020; 52: 801&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437539</ArticleId><ArticleId IdType="pubmed">32888706</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Tenforde MW, Friedman KG et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS&#x2010;C) compared with severe acute COVID&#x2010;19. JAMA 2021; 325: 1074&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne AB, Gilani Z, Godfred&#x2010;Cato S et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS&#x2010;CoV&#x2010;2. JAMA Netw. Open 2021; 4: e2116420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Government Department of Health . COVID&#x2010;19 Australia: Epidemiology Report 25. 23 September 2020.</Citation></Reference><Reference><Citation>Rodriguez&#x2010;Gonzalez M, Castellano&#x2010;Martinez A, Cascales&#x2010;Poyatos HM, Perez&#x2010;Reviriego AA. Cardiovascular impact of COVID&#x2010;19 with a focus on children: A systematic review. World J. Clin. Cases 2020; 8: 5250&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674714</ArticleId><ArticleId IdType="pubmed">33269260</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh&#x2010;Grewal D, Lucas R, McCarthy K et al. Update on the COVID&#x2010;19&#x2010;associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome&#x2010;temporally associated with SARS&#x2010;CoV&#x2010;2. J. Paediatr. Child Health 2020; 56: 1173&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436879</ArticleId><ArticleId IdType="pubmed">32735721</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z et al. Inborn errors of type I IFN immunity in patients with life&#x2010;threatening COVID&#x2010;19. Science 2020; 370: 4570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallerini C, Daga S, Mantovani S et al. Association of Toll&#x2010;like receptor 7 variants with life&#x2010;threatening COVID&#x2010;19 disease in males: Findings from a nested case&#x2010;control study. Elife 2021; 10: 67569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987337</ArticleId><ArticleId IdType="pubmed">33650967</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q et al. Autoantibodies against type I IFNs in patients with life&#x2010;threatening COVID&#x2010;19. Science 2020; 370: eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Orlova E, Sozaeva L et al. Preexisting autoantibodies to type I IFNs underlie critical COVID&#x2010;19 pneumonia in patients with APS&#x2010;1. J. Exp. Med. 2021; 218: e20210554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077172</ArticleId><ArticleId IdType="pubmed">33890986</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus N, Frizinsky S, Hagin D et al. Minor clinical impact of COVID&#x2010;19 pandemic on patients with primary immunodeficiency in Israel. Front. Immunol. 2020; 11: 614086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840610</ArticleId><ArticleId IdType="pubmed">33519822</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyts I, Bucciol G, Quinti I et al. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study. J. Allergy Clin. Immunol. 2020; 147: 520&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832563</ArticleId><ArticleId IdType="pubmed">32980424</ArticleId></ArticleIdList></Reference><Reference><Citation>Goss MB, Galvan NTN, Ruan W et al. The pediatric solid organ transplant experience with COVID&#x2010;19: An initial multi&#x2010;center, multi&#x2010;organ case series. Pediatr. Transplant. 2021; 25: e13868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537006</ArticleId><ArticleId IdType="pubmed">32949098</ArticleId></ArticleIdList></Reference><Reference><Citation>Millen GC, Arnold R, Cazier JB et al. Severity of COVID&#x2010;19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project. Br. J. Cancer 2021; 124: 754&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884399</ArticleId><ArticleId IdType="pubmed">33299130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukkada S, Bhakta N, Chantada GL et al. Global characteristics and outcomes of SARS&#x2010;CoV&#x2010;2 infection in children and adolescents with cancer (GRCCC): A cohort study. Lancet Oncol. 2021; 22: 1416&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389979</ArticleId><ArticleId IdType="pubmed">34454651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciapponi A, Bardach A, Comand&#xe9; D et al. COVID&#x2010;19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes. PLoS One 2021; 16: e0253974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241118</ArticleId><ArticleId IdType="pubmed">34185807</ArticleId></ArticleIdList></Reference><Reference><Citation>Neef V, Buxmann H, Rabenau HF, Zacharowski K, Raimann FJ. Characterization of neonates born to mothers with SARS&#x2010;CoV&#x2010;2 infection: Review and meta&#x2010;analysis. Pediatr. Neonatol. 2021; 62: 11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585378</ArticleId><ArticleId IdType="pubmed">33334687</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschetti R, Vivanti AJ, Vauloup&#x2010;Fellous C, Loi B, Benachi A, De Luca D. Synthesis and systematic review of reported neonatal SARS&#x2010;CoV&#x2010;2 infections. Nat. Commun. 2020; 11: 5164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566441</ArticleId><ArticleId IdType="pubmed">33060565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Zozaya C, Zhou Q, De Castro C, Shah PS. SARS&#x2010;CoV&#x2010;2 genome and antibodies in breastmilk: A systematic review and meta&#x2010;analysis. Arch. Dis. Child 2021; 106: 514&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">33568494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel JP, Tendal B, Giles M et al. Clinical care of pregnant and postpartum women with COVID&#x2010;19: Living recommendations from the national COVID&#x2010;19 clinical evidence taskforce. Aust N Z J Obstet Gynaecol 2020; 60: 840&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820999</ArticleId><ArticleId IdType="pubmed">33119139</ArticleId></ArticleIdList></Reference><Reference><Citation>
The COVID NMA Initiative
2021. Available from: https://covid-nma.com.</Citation></Reference><Reference><Citation>
Living Guidelines: National COVID&#x2010;19 Clinical Evidence Taskforce
2021. Available from: www.covid19evidence.net.au.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538623</ArticleId><ArticleId IdType="pubmed">36150213</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Government Department of Health . Australian prescription medicine decision summaries: Xevudy. 20 August 2021.</Citation></Reference><Reference><Citation>RECOVERY Trial . A randomised trial of treatments to prevent death in patients hospitalised with COVID&#x2010;19 (coronavirus). 2021. Contract No.: ISRCTN50189673.</Citation></Reference><Reference><Citation>Harwood R, Allin B, Jones CE et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID&#x2010;19 (PIMS&#x2010;TS): Results of a national Delphi process. Lancet Child Adoles Health 2021; 5: 133&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500943</ArticleId><ArticleId IdType="pubmed">32956615</ArticleId></ArticleIdList></Reference><Reference><Citation>McArdle AJ, Vito O, Patel H et al. Treatment of multisystem inflammatory syndrome in children. N. Engl. J. Med. 2021; 385: 11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220965</ArticleId><ArticleId IdType="pubmed">34133854</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C, Odd D, Harwood R et al. Deaths in children and Young people in England following SARS&#x2010;CoV&#x2010;2 infection during the first pandemic year: A national study using linked mandatory child death reporting data. Res. Sq. 2021. 10.21203/rs.3.rs-689684/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-689684/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz A, Grant K, Marano R et al. Long&#x2010;term effects of malnutrition on severity of COVID&#x2010;19. Sci. Rep. 2021; 11: 14974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298504</ArticleId><ArticleId IdType="pubmed">34294743</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021; 110: 2208&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet . Understanding long COVID: A modern medical challenge. Lancet 2021; 398: 725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389978</ArticleId><ArticleId IdType="pubmed">34454656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr. Infect. Dis. J. 2021. 10.1097/inf.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/inf.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin&#x2010;Chowdhury Z, Ladhani SN. Causation or confounding: Why controls are critical for characterizing long COVID. Nat. Med. 2021; 27: 1129&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Health Department&#x2010;Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS&#x2010;C) in the United States. Atlanta, GA: CDC; 2021. Available from: https://www.cdc.gov/mis/cases/index.html [accessed 21 August 2021].</Citation></Reference><Reference><Citation>Li B, Deng A, Li K et al. Viral infection and transmission in a large well&#x2010;traced outbreak caused by the Delta SARS&#x2010;CoV&#x2010;2 variant. medRxiv: the preprint server for health sciences 2021: 2021.07.07.21260122.</Citation></Reference><Reference><Citation>Herlihy R, Bamberg W, Burakoff A et al. Rapid increase in circulation of the SARS&#x2010;CoV&#x2010;2 B.1.617.2 (Delta) variant &#x2010; Mesa County, Colorado, April&#x2010;June 2021. MMWR Morb. Mortal. Wkly Rep. 2021; 70: 1084&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360276</ArticleId><ArticleId IdType="pubmed">34383734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>